Literature DB >> 7487920

Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.

H K Kole1, M S Smyth, P L Russ, T R Burke.   

Abstract

In all, 15 aryl-containing phosphonates have been synthesized and tested for their effect on protein-tyrosine phosphatase (PTPase) activity. Two compounds, (naphth-2-yl) difluoromethylphosphonic acid (12) and (napthy-1-yl) difluoromethylphosphonic acid (13) have been found to inhibit dephosphorylation of [32P]insulin receptors by PTP-1B, a protein tyrosine phosphatase (PTPase), with IC50 values of 40-50 microM. Compound 12 competitively inhibited insulin-receptor dephosphorylation by PTP-1B. Compound 12 also inhibited PTP-1B-catalysed dephosphorylation of a synthetic tyrosine phosphorylated substrate poly(Glu80-Tyr20) at the same potency, indicating that 12 acted via interaction with the PTPase. Additionally, 12 inhibited insulin-receptor PTPase(s) and epridermal-growth-factor-receptor PTPase(s) present in solubilized membranes from CHO (Chinese-hamster ovary)/HIRc and A431 cells respectively. IC50 values of 40-50 microM were obtained in all cases with compound 12. Of note is the fact that these compounds did not have any effect on insulin-receptor autophosphorylation. Nine out of the 15 compounds potently inhibited serine/threonine phosphatase PP-2A activity without any effect on serine/threonine phosphatase PP-1 when tested at a concentration as high as 675 microM. The most potent compounds acting toward PP-2A had IC50 values of 45-50 microM. These PP-2A inhibitors could be useful tools for studying serine/threonine-phosphatase-mediated signal transduction. Two compounds, 12 and 13, inhibited both tyrosine phosphatase PTP-1B and serine/threonine phosphatase PP-2A with similar potency; IC50 values being 40-50 microM in both cases. Details of the synthesis of compounds 10, 11 and 13 are given in Supplementary Publication SUP 50177 (6 pages), which has been deposited at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K., from whom copies can be obtained on the terms indicated in Biochem. J. (1995) 305, 9.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487920      PMCID: PMC1136105          DOI: 10.1042/bj3111025

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  1002 protein phosphatases?

Authors:  H Charbonneau; N K Tonks
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase.

Authors:  X M Zheng; Y Wang; C J Pallen
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

3.  Phosphonate-containing inhibitors of tyrosine-specific protein kinases.

Authors:  T R Burke; Z H Li; J B Bolen; V E Marquez
Journal:  J Med Chem       Date:  1991-05       Impact factor: 7.446

4.  Approaches to the molecular cloning of protein-tyrosine phosphatases in insulin-sensitive tissues.

Authors:  B J Goldstein; W R Zhang; N Hashimoto; C R Kahn
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

5.  Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans.

Authors:  M C McGuire; R M Fields; B L Nyomba; I Raz; C Bogardus; N K Tonks; J Sommercorn
Journal:  Diabetes       Date:  1991-07       Impact factor: 9.461

Review 6.  Protein tyrosine phosphatases.

Authors:  K M Walton; J E Dixon
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

7.  Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.

Authors:  S M Domchek; K R Auger; S Chatterjee; T R Burke; S E Shoelson
Journal:  Biochemistry       Date:  1992-10-20       Impact factor: 3.162

8.  Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats.

Authors:  J M Boylan; D L Brautigan; J Madden; T Raven; L Ellis; P A Gruppuso
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

9.  Dephosphorylation of human p34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase.

Authors:  R Honda; Y Ohba; A Nagata; H Okayama; H Yasuda
Journal:  FEBS Lett       Date:  1993-03-08       Impact factor: 4.124

10.  Effect of aging on the kinetic characteristics of the insulin receptor autophosphorylation in rat adipocytes.

Authors:  P Ruíz; J A Pulido; C Martínez; J M Carrascosa; J Satrústegui; A Andrés
Journal:  Arch Biochem Biophys       Date:  1992-07       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.